C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/506 (2006.01) A61K 31/538 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2736258
The present disclosure relates to 2,4-pyrimidinediamines substituted with tricyclic carbamates and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, such as JAK2 or JAK3, is therapeutically useful.
La présente invention concerne des 2,4-pyrimidinediamines substituées par des carbamates tricycliques, et les compositions et procédés utilisant ces composés dans le traitement d'affections dans lesquelles la modulation de la voie JAK ou l'inhibition des kinases JAK, telles que JAK2 ou JAK3, est utile sur le plan thérapeutique.
Bhamidipati Somasekhar
Markovtsov Vadim
Singh Rajinder
Riches Mckenzie & Herbert Llp
Rigel Pharmaceuticals Inc.
LandOfFree
Tricyclic carbamate jak inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic carbamate jak inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic carbamate jak inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1539086